RDI scheme, GST reforms strengthened Indian pharma in 2025: IPA Secretary General - A2Z Taxcorp LLP

The year 2025 has been an inflection point for Indian pharma, signalling the country’s push to move up the value chain. The landmark next-gen GST reform emerged as a key policy milestone, strengthening affordability and expanding patient access to medicines, said Secretary General, Indian Pharmaceutical Alliance. “The government’s focus on quality, reflected in the implementation of the revised Sc…